D
Doris Leithner
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 67
Citations - 1361
Doris Leithner is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 17, co-authored 60 publications receiving 764 citations. Previous affiliations of Doris Leithner include Goethe University Frankfurt & Medical University of Vienna.
Papers
More filters
Journal ArticleDOI
Abbreviated MRI of the Breast: Does It Provide Value?
Doris Leithner,Linda Moy,Elizabeth A. Morris,Maria Adele Marino,Maria Adele Marino,Thomas H. Helbich,Katja Pinker +6 more
TL;DR: Results with abbreviated MRI protocols suggest that it seems feasible to offer screening breast DCE‐MRI to a broader population, and their emerging role in the new value‐based healthcare paradigm that has replaced the fee‐for‐service model is given.
Journal ArticleDOI
Clinical role of breast MRI now and going forward.
Doris Leithner,Georg Wengert,Thomas H. Helbich,Sunitha B. Thakur,R. E. Ochoa-Albiztegui,Elizabeth A. Morris,Katja Pinker,Katja Pinker +7 more
TL;DR: The current clinical role of breast MRI, including multiparametric MRI and abbreviated protocols, and an outlook on the future of this technique are reviewed and the predictive and prognostic value of MRI as well as the evolving field of radiogenomics will be discussed.
Journal ArticleDOI
Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Doris Leithner,Joao V. Horvat,Maria Adele Marino,Maria Adele Marino,Blanca Bernard-Davila,Maxine S. Jochelson,R. Elena Ochoa-Albiztegui,Danny F. Martinez,Elizabeth A. Morris,Sunitha B. Thakur,Katja Pinker +10 more
TL;DR: In this preliminary study, radiomic signatures with CE-MRI enable the assessment of breast cancer receptor status and molecular subtypes with high diagnostic accuracy.
Journal ArticleDOI
Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Joao V. Horvat,Blanca Bernard-Davila,Thomas H. Helbich,Michelle Zhang,Elizabeth A. Morris,Sunitha B. Thakur,R. Elena Ochoa-Albiztegui,Doris Leithner,Maria Adele Marino,Pascal A. T. Baltzer,Paola Clauser,Panagiotis Kapetas,Zsuzsanna Bago-Horvath,Katja Pinker,Katja Pinker +14 more
TL;DR: Diffusion‐weighted imaging with apparent diffusion coefficient (ADC) mapping is one of the most useful additional MRI parameters to improve diagnostic accuracy and is now often used in a multiparameric imaging setting for breast tumor detection and characterization.
Journal ArticleDOI
Virtual Monoenergetic Imaging and Iodine Perfusion Maps Improve Diagnostic Accuracy of Dual-Energy Computed Tomography Pulmonary Angiography With Suboptimal Contrast Attenuation
Doris Leithner,Julian L. Wichmann,Thomas J. Vogl,Jesko Trommer,Simon S. Martin,Jan-Erik Scholtz,Boris Bodelle,Carlo N. De Cecco,Taylor M. Duguay,John W. Nance,U. Joseph Schoepf,Moritz H. Albrecht +11 more
TL;DR: A reconstruction protocol including 40-keV VMI+ series and DECT-PM improves reader confidence and diagnostic accuracy for segmental PE detection compared with standard M_0.6 images in DE-CTPA with suboptimal contrast attenuation.